Open Access Research

Diagnosis and mortality in 47,XYY persons: a registry study

Kirstine Stochholm1, Svend Juul2 and Claus H Gravholt1*

Author Affiliations

1 Department of Internal Medicine and Endocrinology, Aarhus Sygehus, Aarhus University Hospital, Norrebrogade 44, 8000 Aarhus C, Denmark

2 Department of Epidemiology, School of Public Health, Aarhus University, Denmark

For all author emails, please log on.

Orphanet Journal of Rare Diseases 2010, 5:15 doi:10.1186/1750-1172-5-15

Published: 29 May 2010

Abstract

Background

Sex chromosomal abnormalities are relatively common, yet many aspects of these syndromes remain unexplored. For instance epidemiological data in 47,XYY persons are still limited.

Methods

Using a national Danish registry, we identified 208 persons with 47,XYY or a compatible karyotype, whereof 36 were deceased; all were diagnosed from 1968 to 2008. For further analyses, we identified age matched controls from the male background population (n = 20,078) in Statistics Denmark. We report nationwide prevalence data, data regarding age at diagnosis, as well as total and cause specific mortality data in these persons.

Results

The average prevalence was 14.2 47,XYY persons per 100,000, which is reduced compared to the expected 98 per 100,000. Their median age at diagnosis was 17.1 years. We found a significantly decreased lifespan from 77.9 years (controls) to 67.5 years (47,XYY persons). Total mortality was significantly increased compared to controls, with a hazard ratio of 3.6 (2.6-5.1). Dividing the causes of deaths according to the International Classification of Diseases, we identified an increased hazard ratio in all informative chapters, with a significantly increased ratio in cancer, pulmonary, neurological and unspecified diseases, and trauma.

Conclusion

We here present national epidemiological data regarding 47,XYY syndrome, including prevalence and mortality data, showing a significantly delay to diagnosis, reduced life expectancy and an increased total and cause specific mortality.